The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients

Journal of the Chinese Medical Association

Volumn 67, Issue 5, 2004, Pages 217-221

  Erten, Nilgun ^a   Genc, Sema ^a   Besisik, Sevgi K ^a,b   Saka, Bulent ^a   Karan, M Akif ^a   Tascioglu, Cemil ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Calcitonin; Fever; Neutropenia; Procalcitonin; Protein precursor

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MALE; PREDICTION; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; FEVER; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS;

EID: 4043184209     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64: 328-40.
2. De Pauw BE. The sequence of infective events in prolonged neutropenia. In: Klastersky JA, ed. Febrile Neutropenia. Berlin: Springer-Verlag, 1997;35-40.
3. Lee JW, Pizzo PA. Management of cancer patient with fever and prolonged neutropenia. Hematol Oncol Clin N 1993;7: 937-60.
4. Escalante CP, Rubenstein EB, Rolston KV. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer. Cancer Invest 1997;15:237-42.
5. Talcott JA. Assessing risk in cancer patients with fever and neutropenia. In: Klastersky JA, ed. Febrile Neutropenia. Berlin: Springer-Verlag, 1997;23-7.
6. Paesmans M. Risk factors assessment in febrile neutropenia. Int J Antimicrob Agents 2000;16:107-11.
7. Tice AD. Outpatient parenteral antibiotic therapy for fever and neutropenia. Infect Dis Clin N Am 1998;12:963-77.
8. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al. 1999 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Disease Society of America. Clin Infect Dis 1997;25: 551-73.
9. Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:57-61.
10. Ruokonen E, Nousiainen K, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol 1999;18:283-5.
11. Kallio R, Surcel HM, Bloigu A, Syrjala H. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000;36:889-94.
12. Sudhoff T, Giagounidis A, Karthaus M. Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practice. Chemotherapy 2000;46:77-85.
13. Waage A, Steinshamn S. Cytokine mediators of septic infections in the normal and granulocytopenic host. Eur J Haematol 1993;50:243-9.
14. Engervall P, Granstrom M, Andersson B, Bjorkholm M. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentration in neutropenic patients with fever. Eur J Haematol 1995;54:226-34.
15. Manian FA. A prospective study of daily measurement of C-reactive protein in serum of adult neutropenia. Clin Infect Dis 1995;21:114-21.
16. Sudhoff T, Giagounidis A, Karthaus M. Serum and plasma parameters in clinical evaluation of neutropenic fever. Antibiot Chemother 2000;50:10-9.
17. Giamarellos-Bourbolis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001;32: 1718-25.
18. Lacour AG, Gervaix A, Zamora SA, Vadas L, Lombard PR, Dayer JM, Suter S. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr 2001;160:95-100.
19. Kohli V, Singhi S, Sharma P, Ganguly NK. Value of serum C-reactive protein concentrations in febrile children without apparent focus. Ann Trop Paediatr 1993;13:373-8.
20. Arber C, Passweg JR, Fluckiger U, Pless M, Gregor M, Tichelli A, et al. C-reactive protein and fever in neutropenic patients. Scand J Infect Dis 2000;32:515-20.
21. Fleishback G, Kambeck I, Dubravka C, Hasan C. Procalcitonin in pediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin-2 receptor and soluble tumor necrosis factor receptor II. Brit J Haematol 2000;111:1093-102.
22. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bouhon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
23. Engel A, Steinbach G, Kern P, Kern WV. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999;31: 185-9.